INDIANAPOLIS, March 25 Concentrics Research LLC, a privately held business specializing in consumer healthcare research and late-stage clinical research, has received national certification as a Women's Business Enterprise by the Women's Business Enterprise Council - Great Lakes [a regional certifying partner of the Women's Business Enterprise National Council (WBENC)]. Celebrating their 25th Anniversary, Concentrics Research highlights this designation as they further strengthen partnerships with a growing network of pharmaceutical and medical device companies throughout the United States.
"We are very excited about this national certification and it coincides with our plans for further expansion. Concentrics remains committed to furthering the health and quality of life for consumers by partnering with our sponsors on innovative research programs," Concentrics Research President and CEO Julie L. Aker said. "We have been involved in 76% of the successful Rx-to-OTC Switch programs and have more than doubled our client base over the last five years. This certification will open the door to new opportunities and we look forward to expanding our reach and the impact we can make in the industry."
WBENC's national standard of certification confirms a business is at least 51% owned, operated and controlled by a woman or women. By including women-owned businesses among their vendors, corporations and government agencies demonstrate their commitment to fostering diversity and the continued development of their supplier/vendor diversity programs.
Concentrics works with Fortune 100 pharmaceutical and device companies to provide a full range of contract research organization (CRO) services that range from program strategy and FDA interactions to protocol development and full study execution for Rx-to-OTC Switch programs, clinical studies (Phase II-IV), behavioral studies related to Rx-to-OTC Switch (label comprehension, self-selection and actual use) and healthcare marketing research studies to support claims and line extensions. Concentrics also is widely known for their expertise with REMS (Risk Evaluation and Mitigation Strategies), a growing area resulting from recent FDA expectations.
To learn more about Concentrics Research, visit www.concentricsresearch.com
Concentrics Research is a late-stage contract research organization that serves the pharmaceutical and device industries. The Company is devoted to client-centered strategies for Rx-to-OTC Switch programs, consumer healthcare research and Phase II-IV clinical trials.
SOURCE Concentrics Research LLC